Health Care Technology · Nasdaq
WAYWaystar Holding Corp.
- Last close
- $27.99 -0.5%
- 52-week range
- $17.26 to $37.51
- Market cap
- $5.39B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Revenue
$1.10B
+16% vs FY24
Net income
$112M
+686% vs FY24
Free cash flow
$283M
+99% vs FY24
Net cash
-$1.39B
Cash $86.2M, debt $1.47B
Stock price
Valuation vs its own history since 2024
Below its median since 2024 on all 3 multiples
Where each multiple sits today inside its own range since 2024, measured at every quarter end. The thin tick is the median.
P/E, trailing
40.4x
n/a: Not enough history
Price / sales
4.3x
3.3x7.3x
40th percentile, below its median of 5.6x
EV / EBITDA
14.9x
12.2x23.5x
40th percentile, below its median of 20.0x
Price / free cash flow
20.4x
16.0x1,053x
30th percentile, below its median of 25.4x
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 40.4x
- Earnings yield
- 2.5%
- Price / sales
- 4.3x
- Price / book
- 1.3x
- Price / operating cash flow
- 17.1x
- EV / EBITDA
- 14.9x
- EV / sales
- 5.2x
- Free cash flow yield
- 4.9%
Profitability
- Gross margin
- 69.4%
- Operating margin
- 21.9%
- Net margin
- 10.7%
- Return on equity
- 3.3%
- Return on capital
- 3.5%
Growth per year
- Revenue, 3 years
- +16.0%
- Revenue, 5 years
- n/aLess than 5 years of history
- EPS, 3 years
- n/aNot meaningful (a loss in the window)
Balance sheet
- Cash and investments
- $277M
- Total debt
- $1.46B
- Net cash
- -$1.19B
- Debt / equity
- 0.36x
- Current ratio
- 2.10x
Shares and dividend
- Shares outstanding
- 192M
- Share count, 5 years
- n/aLess than 5 years of history
- Beta, 1 year
- 0.55
- Dividend yield
- n/a
- Dividend per share, TTM
- n/a
- Payout ratio
- n/a
n/a: No dividend
Every year we have of the business
Last 14 quarters, fiscal 2022 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2022 to 2025.
Revenue and net incomeLatest quarter $326M
RevenueNet income
Gross profitLatest quarter $226M
EBITDALatest quarter $103M
Margins70 / 19 / 10%
GrossOperatingNet
Earnings per shareLatest quarter $0.16
Cash flowLatest quarter $104M
OperatingCapexFree
Cash vs debtLatest quarter $277M
Cash and investmentsTotal debt
P/E historyNow 40.4x
P/E
P/S historyNow 4.3x
P/S, median 5.6x dashed
Revenue and net incomeFY25 $1.10B
RevenueNet income
Gross profitFY25 $751M
EBITDAFY25 $390M
Margins68 / 23 / 10%
GrossOperatingNet
Earnings per shareFY25 $0.61
Cash flowFY25 $310M
OperatingCapexFree
Cash vs debtFY25 $86.2M
Cash and investmentsTotal debt
P/S historyNow 4.3x
P/S, median 5.6x dashed
Where the revenue comes from
Subscription and Circulation went from 52% to 51% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
FY22
$705M
FY23
$791M
FY24
$944M
FY25
$1.10B
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| Subscription and Circulation | $558M | 50.8% | +22% |
| Volume Based Revenue | $535M | 48.6% | +11% |
| Implementation Services and Other Revenue | $6.12M | 0.6% | +8% |
Health Care Technology peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc | $48.8B | +16% | 29.9% | 49.4x | 14.1x | 8th percentile |
| DOCS Doximity, Inc. | $5.95B | +6% | 26.3% | 46.4x | 9.0x | 36th percentile |
| WAY Waystar Holding Corp. | $5.39B | +21% | 21.9% | 40.4x | 4.3x | Not enough history |
| SDGR Schrodinger, Inc. | $1.86B | +5% | -49.6% | No earnings | 6.9x | No earnings |
The company
- Sector
- Health Care
- Industry
- Health Care Technology
- Headquarters
- Lehi, UT
- Fiscal year ends
- December
Around the numbers
What the rest of EdgeStacker knows about WAY.